Reporter, Medtech Insight
Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.
Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.
Latest From Barnaby Pickering
A “federated” training method could be used to reduce bias in AI, according to one expert on patient safety.
Cumulus Neuroscience, previously known as BrainWaveBank, announced a £6m financing round to help develop its unique neurological data collection system.
Inivata will remain a separate liquid biopsy division alongside NeoGenomics’ growing clinical, pharma and informatics divisions.
Baxter International recorded slight revenue increases during quarter one of 2021, with sales still impacted by COVID-19. Its board remains optimistic , pointing towards new product releases and “operational strength” as redeeming factors.
Integra's first-quarter revenue was up less than 3%, year over year, but the company reported the integration of the ACell regenerative technology business is ahead of schedule
In this week’s podcast, Medtech Insight's Barnaby Pickering features Finnish start-up GlucoModicum, which created a way to measure blood glucose levels without using needles. Managing editor Marion Webb discusses her latest Market Intel, which highlights three companies that developed technologies to help surgeons collaborate with remote surgical experts, including medical device specialists.